Smokeless tobacco use is highly prevalent in India, especially among patients with coronary artery disease (CAD). Understanding the barriers to cessation in this group is crucial for developing effective interventions.
This explainer provides insights into the challenges faced by CAD patients in quitting smokeless tobacco and discusses the importance of tailored public health strategies.
This page provides an explainer summary based on the available research paper information. It is not a copy of the original paper. For complete methodology, data, findings, and full text, please visit the original source.
View Original SourceAddressing the barriers to quitting smokeless tobacco among CAD patients is vital for reducing cardiovascular mortality rates. Tailored interventions can significantly improve cessation success rates.
This understanding can guide policymakers and health professionals in creating effective, culturally sensitive cessation programs.
Reducing smokeless tobacco use among CAD patients can lead to significant improvements in public health outcomes, including lower mortality and morbidity rates.
Effective cessation strategies are essential for comprehensive cardiovascular disease prevention efforts in India and similar contexts.
Insights from this study can inform policy development aimed at tobacco control and cessation support, especially targeting high-risk groups like CAD patients.
Policies that address cultural and social barriers can enhance the effectiveness of tobacco cessation programs.
بھارت میں دل کی بیماری کے مریضوں کے لیے تمباکو نوشی چھوڑنے میں رکاوٹوں کو سمجھنا بہت اہم ہے۔ یہ معلومات صحت کے حکام اور پالیسی سازوں کے لیے مددگار ثابت ہو سکتی ہیں۔
تمباکو نوشی کے خلاف مؤثر اقدامات اور مہمات کے لیے یہ سمجھ ضروری ہے تاکہ مریضوں کی مدد کی جا سکے اور صحت کے نتائج بہتر بنائے جا سکیں۔
Choose how you want to understand this article. The AI can explain it in simple language, Urdu, bullet points, Q&A, policy brief, or research-style notes using the available explainer content and original source link where possible.
This feature is powered by AI and is intended to help readers better understand research papers, reports, articles, and public-health information. AI-generated responses may occasionally be incomplete or limited. This feature does not replace the original source, medical advice, professional research review, or official policy guidance. For complete methodology, data, findings, and full text, please refer to the original source.